111 (YI) EBITDA Margin Growth (3y) (2020 - 2025)
111 (YI) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 81.00 |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 58.00 |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -30.00 |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -32.00 |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 260.00 |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 234.00 |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 296.00 |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 18,262.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 928.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 260.00 |
| Sep 30, 2025 | 243.00 |
| Jun 30, 2025 | 267.00 |
| Mar 31, 2025 | 343.00 |
| Dec 31, 2024 | 283.00 |
| Sep 30, 2024 | 530.00 |
| Jun 30, 2024 | 634.00 |
| Mar 31, 2024 | 686.00 |
| Dec 31, 2023 | 45.00 |
| Sep 30, 2023 | 286.00 |
| Jun 30, 2023 | 451.00 |
| Mar 31, 2023 | 673.00 |
| Dec 31, 2022 | -1,508.00 |
| Sep 30, 2022 | -1,314.00 |
| Jun 30, 2022 | 945.00 |
| Mar 31, 2022 | 1,272.00 |
| Dec 31, 2021 | -2,674.00 |
| Sep 30, 2021 | -3,135.00 |
| Jun 30, 2021 | 1,774.00 |
| Mar 31, 2021 | 602.00 |